FIKVX
Price
$14.90
Change
+$0.03 (+0.20%)
Updated
Jun 2 closing price
Net Assets
6.32B
PACRX
Price
$12.05
Change
+$0.03 (+0.25%)
Updated
Jun 2 closing price
Net Assets
837.51M
Interact to see
Advertisement

FIKVX vs PACRX

Header iconFIKVX vs PACRX Comparison
Open Charts FIKVX vs PACRXBanner chart's image
FIKVX vs PACRX Comparison Chart in %
View a ticker or compare two or three
VS
FIKVX vs. PACRX commentary
Jun 04, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FIKVX is a Buy and PACRX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
FIKVX has more cash in the bank: 6.32B vs. PACRX (838M). FIKVX pays higher dividends than PACRX: FIKVX (3.05) vs PACRX (2.70). FIKVX was incepted earlier than PACRX: FIKVX (8 years) vs PACRX (23 years). PACRX (1.21) is less costly to investors than FIKVX (0.48). PACRX is a more actively managed with annual turnover of: 243.00 vs. FIKVX (31.00). FIKVX (0) and PACRX (0) have matching initial minimum investment requirements. FIKVX annual gain was more profitable for investors over the last year : 11.47 vs. PACRX (10.68). FIKVX return over 5 years is better than : 17.13 vs. PACRX (9.91).
FIKVXPACRXFIKVX / PACRX
Total Expense Ratio0.451.2137%
Annual Report Gross Expense Ratio0.481.2140%
Fund Existence8 years23 years-
Gain YTD4.3113.575121%
Front LoadN/AN/A-
Min. Initial Investment00-
Min. Initial Investment IRAN/AN/A-
Net Assets6.32B838M754%
Annual Yield % from dividends3.052.70113%
Returns for 1 year11.4710.68107%
Returns for 3 years25.7129.6787%
Returns for 5 years17.139.91173%
Returns for 10 yearsN/A36.07-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
UBSI43.500.86
+2.02%
United Bankshares
SO90.511.48
+1.66%
Southern Company (The)
RAAQ11.780.11
+0.94%
Real Asset Acquisition Corp
AFYA14.38-0.14
-0.96%
Afya Limited
RMTI0.71-0.01
-1.27%
Rockwell Medical